Literature DB >> 11448327

Development of the 25-item National Eye Institute Visual Function Questionnaire.

C M Mangione1, P P Lee, P R Gutierrez, K Spritzer, S Berry, R D Hays.   

Abstract

OBJECTIVE: To develop and test the psychometric properties of a 25-item version of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25).
DESIGN: Prospective observational cohort study of persons with 1 of 5 chronic eye diseases or low vision who were scheduled for nonurgent visits in ophthalmology practices and a reference sample of persons without eye disease.
SETTING: Eleven university-based ophthalmology practices and the NEI Clinical Center. PATIENTS: Eligible participants had to have 1 of the following eye conditions: age-related cataracts, age-related macular degeneration, diabetic retinopathy, primary open-angle glaucoma, cytomegalovirus retinitis, or low vision from any cause. Seven of the 12 sites also enrolled persons in a reference sample. Reference sample participants had no evidence of underlying eye disease but were scheduled for either screening eye examinations or correction of refractive error. All eligible persons had to be 21 years or older, English speaking, and cognitively able to give informed consent and participate in a health status interview.
MEASUREMENTS AND MAIN RESULTS: To provide the data needed to create the NEI VFQ-25, all subjects completed an interview that included the 51-item NEI VFQ. Estimates of internal consistency indicate that the subscales of the NEI VFQ-25 are reliable. The validity of the NEI VFQ-25 is supported by high correlations between the short- and long-form versions of the measure, observed between-group differences in scores for persons with different eye diseases of varying severity, and the moderate-to-high correlations between the NEI VFQ-25 subscales that have the most to do with central vision and measured visual acuity.
CONCLUSIONS: The reliability and validity of the NEI VFQ-25 are comparable to those of the 51-item NEI VFQ field test version of the survey. This shorter version will be more feasible in settings such as clinical trials where interview length is a critical consideration. In addition, preliminary analyses indicate that the psychometric properties of the NEI VFQ-25 are robust for the eye conditions studied; this suggests that the measure will provide reproducible and valid data when used across multiple conditions of varying severity.

Entities:  

Mesh:

Year:  2001        PMID: 11448327     DOI: 10.1001/archopht.119.7.1050

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  609 in total

1.  Vision-specific health-related quality of life: content areas for nursing home residents.

Authors:  Kay Scilley; Cynthia Owsley
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

2.  A comparison of findings on parents' and teachers' questionnaires, and detailed ophthalmic and psychological assessments.

Authors:  A R O'Connor; T J Stephenson; A Johnson; S D Wright; M J Tobin; S Ratib; A R Fielder
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

3.  Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Authors:  Kevin D Frick; Lea T Drye; John H Kempen; James P Dunn; Gary N Holland; Paul Latkany; Narsing A Rao; H Nida Sen; Elizabeth A Sugar; Jennifer E Thorne; Robert C Wang; Janet T Holbrook
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

4.  Psychometric performance of the national eye institute 25-item visual function questionnaire: in Turkish diabetic retinopathy patients.

Authors:  Akinci Fevzi; Yildirim Aysegul
Journal:  Patient       Date:  2008-04-01       Impact factor: 3.883

5.  Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study.

Authors:  Roberta McKean-Cowdin; Ying Wang; Joanne Wu; Stanley P Azen; Rohit Varma
Journal:  Ophthalmology       Date:  2007-11-12       Impact factor: 12.079

6.  Long-term prognosis for glaucoma in patients with Posner-Schlossman syndrome.

Authors:  Jin-Ho Kim; Ji-Young Lee; Jin A Choi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-23       Impact factor: 3.117

7.  [The influence of visual rehabilitation on secondary depressive disorders due to age-related macular degeneration. A randomized controlled pilot study].

Authors:  A Mielke; K Wirkus; R Niebler; G Eschweiler; N X Nguyen; S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

8.  Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.

Authors:  Yoshifumi Okamoto; Fumiki Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Jpn J Ophthalmol       Date:  2014-04-29       Impact factor: 2.447

9.  Screening older people for impaired vision in primary care: cluster randomised trial.

Authors:  Liam Smeeth; Astrid E Fletcher; Smita Hanciles; Jennifer Evans; Richard Wormald
Journal:  BMJ       Date:  2003-11-01

10.  Use of prescribed optical devices in age-related macular degeneration.

Authors:  Dawn K Decarlo; Gerald McGwin; Karen Searcey; Liyan Gao; Marsha Snow; Lynne Stevens; Cynthia Owsley
Journal:  Optom Vis Sci       Date:  2012-09       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.